SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001493152-18-015980
Filing Date
2018-11-14
Accepted
2018-11-14 14:04:44
Documents
53
Period of Report
2018-09-30

Document Format Files

Seq Description Document Type Size
1 form10-q.htm 10-Q 767821
2 ex31-1.htm EX-31.1 17231
3 ex31-2.htm EX-31.2 16914
4 ex32-1.htm EX-32.1 6893
5 ex32-2.htm EX-32.2 6787
  Complete submission text file 0001493152-18-015980.txt   3599335

Data Files

Seq Description Document Type Size
6 XBRL INSTANCE FILE prph-20180930.xml EX-101.INS 526367
7 XBRL SCHEMA FILE prph-20180930.xsd EX-101.SCH 49283
8 XBRL CALCULATION FILE prph-20180930_cal.xml EX-101.CAL 60445
9 XBRL DEFINITION FILE prph-20180930_def.xml EX-101.DEF 149672
10 XBRL LABEL FILE prph-20180930_lab.xml EX-101.LAB 337956
11 XBRL PRESENTATION FILE prph-20180930_pre.xml EX-101.PRE 233142
Mailing Address 621 N. SHADY RETREAT ROAD DOYLESTOWN PA 18901
Business Address 621 N. SHADY RETREAT ROAD DOYLESTOWN PA 18901 2153450919
ProPhase Labs, Inc. (Filer) CIK: 0000868278 (see all company filings)

IRS No.: 232577138 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 000-21617 | Film No.: 181182561
SIC: 2834 Pharmaceutical Preparations
Assistant Director 1